DBV Technologies S.A.
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Information Regarding the Total number of Voting Rights and
Total Number of Shares of the Company as of December 31, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
| Notice: This document supersedes and replaces the information previously published on January 5, 2026, to account for the earlier exercise of various securities instruments, in connection with the Company’s employee stock ownership plans and warrants from a previous financing transaction. |
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
| Date | Total number of shares | Total number of voting rights |
| 12/31/2025 | 235,670,864 | Total gross of voting rights: 235,670,864 |
| Total net* of voting rights: 235,596,284 |
* Net total = total number of voting rights attached to shares – shares without voting rights
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Theon International PLC12.1.2026 18:18:58 CET | Press release
INTEGRATED MULTI-THREAT HEADBORNE SYSTEM PROTOTYPE TO BE FUNDED AND DEVELOPED FOR U.S. ARMY BY TEAM WENDY CERADYNE AND THEON INTERNATIONAL
Aspo Plc12.1.2026 17:30:00 CET | Press release
Aspo Plc: Share repurchase 12.1.2026
KommuneKredit12.1.2026 17:06:50 CET | Press release
Financial Calendar 2026
KommuneKredit12.1.2026 17:06:50 CET | Pressemeddelelse
Finanskalender 2026
Biogen Inc.12.1.2026 17:05:00 CET | Press release
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom